We have identified multiple genetic variants associated with antibody immune response to 13 infections, many of which are biologically plausible therapeutic or vaccine targets. This may help prioritize future research and drug development.
No takes yet. Share an insight, caveat, or question.
Butler‐Laporte et al. (2020) studied this question.